Latest filing published 16 Jun 2023 for Standard Biotools INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Laura Clague span 3 companies, the busiest being Travere Therapeutics, Inc., Genasys Inc. and Standard Biotools Inc. Over a trading history stretching from 11 May 2021 to 14 June 2023, the count stands at 12 filings.
Sales make up the whole of the open-market record (3 sales, €94k). Besides market trades, the filings include 7 share grants and 2 option exercises.
Most recently, on 16 June 2023, the filings show a share grant in Standard Biotools Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations